why choose us

300×250 Ad Slot

Research Article: Fremanezumab for Episodic Migraine Prevention in Japanese Patients: Subgroup Analysis from Two International Trials

Date Published: 2023-05-18

Introduction:
Episodic migraine (EM), defined as “< migraine or headache days per month with or without aura”, causes less headache-related disability, impairment in quality of life, and comorbidity than chronic migraine (CM). – However, EM is responsible for >% of the migraine cases, and progresses to CM in a small proportion of patients annually and, conversely, CM may switch back to EM.

Read more

300×250 Ad Slot